Dataset from A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone

Pemphigus vulgaris (PV) is a rare skin disorder that causes blistering of the skin and mucous membranes. Infliximab is a man-made antibody used to treat certain types of immune system disorders, including rheumatoid arthritis and Crohn's disease. This study will determine if infliximab given in combination with prednisone is a safe and effective treatment for adults with PV.

寻常型天疱疮（Pemphigus vulgaris, PV）是一种罕见的皮肤疾病，可引发皮肤及黏膜水疱。英夫利昔单抗（Infliximab）是一种人工合成抗体，用于治疗类风湿关节炎、克罗恩病等免疫系统相关疾病。本研究旨在评估英夫利昔单抗联合泼尼松治疗成人寻常型天疱疮的安全性与有效性。